Delayed onset of cutaneous symptoms in erythropoietic protoporphyria [21]

British Journal of Dermatology

Volumn 143, Issue 1, 2000, Pages 221-223

  Varma, S ^a   Haworth, A ^a,b   Keefe, M ^a,b   Anstey, A V ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; CHLORTETRACYCLINE; PORPHYRIN; TERFENADINE; TRIAMCINOLONE;

CASE REPORT; CHILD; ERYTHROPOIETIC PROTOPORPHYRIA; FLUORESCENCE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0033914520     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03637.x     Document Type: Letter

References (12)

1. 1 Murphy GM. The cutaneous porphyria: a review. Br J Dermatol 1999 ; 140: 573–81.
2. 2 Todd DJ. Erythropoietic protoporphyria. Br J Dermatol 1994 ; 131: 750–66.
3. 3 Schmidt H, Snitker G, Thomsen K, Lintrup J. Erythropoietic protoporphyria. A clinical study based on 29 cases in 14 families. Arch Dermatol 1974 ; 110: 58–64.
4. 4 Deleo VA, Poh‐Fitzpatrick MB, Mathews‐Roth M, Harber LC. Erythropoietic protoporphyria–10 years’ experience. Am J Med 1976 ; 60: 8–22.
5. 5 Poh‐Fitzpatrick MB. The ‘priming phenomenon’ in the acute phototoxicity of erythropoietic protoporphyria. J Am Acad Dermatol 1989 ; 21: 311.
6. 6 Murphy GM, Hawk JLM, Corbett MF et al. The U.K. erythropoietic protoporphyria register: a progress report. Br J Dermatol 1985 ; 113 (Suppl. 29): 11.
7. 7 Haberman HF, Menon IA. Mechanism of photosensitivity due to porphyrins: chemical species involved and relevance to clinical porphyrias. In: Fuchs J & Packer L. eds. Oxidative Stress in Dermatology. New York: Marcel Dekker, 1993: 361–74.
8. 8 Mathews‐Roth MM, Pathak MA, Fitzpatrick TB et al. Beta‐carotene as a photoprotective agent in erythropoietic protoporphyria. N Engl J Med 1970 ; 282: 1231–4.
9. 9 Mathews‐Roth MM, Rosner B, Benfell K, Roberts JE. A double‐blind study of cysteine photoprotection in erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed 1994 ; 10: 244–8.
10. 10 Boffa MJ, Ead RD, Reed P, Weinkove C. A double‐blind, placebo‐controlled, crossover trial of oral vitamin C in erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed 1996 ; 12: 27–30.
11. 11 Mathews‐Roth MM, Michel JL, Wise RJ. Amelioration of the metabolic defect in erythropoietic protoporphyria by expression of human ferrochelatase in cultured cells. J Invest Dermatol 1995 ; 104: 497–9.
12. 12 Norris PG, Nunn AV, Hawk JLM, Cox TM. Genetic heterogeneity in erythropoietic protoporphyria: a study of the enzymatic defect in nine affected families. J Invest Dermatol 1990 ; 95: 260–3.